Trial Profile
An Open-label Extension Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Patients With Epilepsy Consisting of Uncontrolled Partial-onset Seizures
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jan 2023
Price :
$35
*
At a glance
- Drugs Ganaxolone (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors Marinus Pharmaceuticals
- 20 Mar 2014 New trial record